Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain ...

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...

Alongside her husband, Bob Duggan, Maky Zanganeh has guided cancer drug developer Summit Therapeutics to reach staggering new ...

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...